Product Code: ETC8853920 | Publication Date: Sep 2024 | Updated Date: Jun 2025 | Product Type: Market Research Report | |
Publisher: 6Wresearch | Author: Summon Dutta | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
The urticaria treatment market in the Philippines is witnessing growth driven by increasing dermatological awareness and improved diagnosis of chronic skin allergies. Antihistamines remain the first-line therapy, with corticosteroids and immunomodulators being used for severe or resistant cases. The urban population shows greater access to dermatological consultations, which supports market expansion.
The market for urticaria treatment is growing alongside rising allergy prevalence. Antihistamines remain widely used, while newer biologics for chronic casessuch as omalizumabare driving specialist clinic adoption. Urban hospitals are leading awareness efforts and diagnostic access.
The urticaria treatment market struggles with underdiagnosis and self-medication practices, particularly for chronic cases. Access to dermatologists is limited, especially in rural areas. Moreover, patients often delay seeking treatment due to the intermittent nature of symptoms, reducing market consistency.
The urticaria (hives) treatment market offers investment potential in over-the-counter antihistamines and prescription biologics. With increasing awareness and diagnosis rates, investors can explore distribution deals with pharmaceutical brands or support dermatology clinics with education and sampling campaigns.
Drugs for urticaria (hives) are regulated by the FDA under standard pharmacological product regulations. Anti-allergic medications must have market authorization, and over-the-counter versus prescription classifications are strictly observed. The DOH includes urticaria treatment in public health center protocols, especially in allergy-prone areas. The government ensures medicine access through the Philippine National Formulary and subsidy programs for vulnerable populations under PhilHealth.
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Philippines Urticaria Treatment Market Overview |
3.1 Philippines Country Macro Economic Indicators |
3.2 Philippines Urticaria Treatment Market Revenues & Volume, 2021 & 2031F |
3.3 Philippines Urticaria Treatment Market - Industry Life Cycle |
3.4 Philippines Urticaria Treatment Market - Porter's Five Forces |
3.5 Philippines Urticaria Treatment Market Revenues & Volume Share, By Disease Type, 2021 & 2031F |
3.6 Philippines Urticaria Treatment Market Revenues & Volume Share, By Drug Type, 2021 & 2031F |
3.7 Philippines Urticaria Treatment Market Revenues & Volume Share, By Route Of Administration, 2021 & 2031F |
3.8 Philippines Urticaria Treatment Market Revenues & Volume Share, By Distribution Channel, 2021 & 2031F |
4 Philippines Urticaria Treatment Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.3 Market Restraints |
5 Philippines Urticaria Treatment Market Trends |
6 Philippines Urticaria Treatment Market, By Types |
6.1 Philippines Urticaria Treatment Market, By Disease Type |
6.1.1 Overview and Analysis |
6.1.2 Philippines Urticaria Treatment Market Revenues & Volume, By Disease Type, 2021- 2031F |
6.1.3 Philippines Urticaria Treatment Market Revenues & Volume, By Acute Urticaria, 2021- 2031F |
6.1.4 Philippines Urticaria Treatment Market Revenues & Volume, By Chronic Urticaria, 2021- 2031F |
6.2 Philippines Urticaria Treatment Market, By Drug Type |
6.2.1 Overview and Analysis |
6.2.2 Philippines Urticaria Treatment Market Revenues & Volume, By Antihistamines, 2021- 2031F |
6.2.3 Philippines Urticaria Treatment Market Revenues & Volume, By H2-blockers, 2021- 2031F |
6.2.4 Philippines Urticaria Treatment Market Revenues & Volume, By Monoclonal Antibodies, 2021- 2031F |
6.2.5 Philippines Urticaria Treatment Market Revenues & Volume, By Antidepressants, 2021- 2031F |
6.2.6 Philippines Urticaria Treatment Market Revenues & Volume, By Others, 2021- 2031F |
6.3 Philippines Urticaria Treatment Market, By Route Of Administration |
6.3.1 Overview and Analysis |
6.3.2 Philippines Urticaria Treatment Market Revenues & Volume, By Oral, 2021- 2031F |
6.3.3 Philippines Urticaria Treatment Market Revenues & Volume, By Topical, 2021- 2031F |
6.3.4 Philippines Urticaria Treatment Market Revenues & Volume, By Parenteral, 2021- 2031F |
6.4 Philippines Urticaria Treatment Market, By Distribution Channel |
6.4.1 Overview and Analysis |
6.4.2 Philippines Urticaria Treatment Market Revenues & Volume, By Hospital Pharmacies, 2021- 2031F |
6.4.3 Philippines Urticaria Treatment Market Revenues & Volume, By Retail Pharmacies, 2021- 2031F |
6.4.4 Philippines Urticaria Treatment Market Revenues & Volume, By Others, 2021- 2031F |
7 Philippines Urticaria Treatment Market Import-Export Trade Statistics |
7.1 Philippines Urticaria Treatment Market Export to Major Countries |
7.2 Philippines Urticaria Treatment Market Imports from Major Countries |
8 Philippines Urticaria Treatment Market Key Performance Indicators |
9 Philippines Urticaria Treatment Market - Opportunity Assessment |
9.1 Philippines Urticaria Treatment Market Opportunity Assessment, By Disease Type, 2021 & 2031F |
9.2 Philippines Urticaria Treatment Market Opportunity Assessment, By Drug Type, 2021 & 2031F |
9.3 Philippines Urticaria Treatment Market Opportunity Assessment, By Route Of Administration, 2021 & 2031F |
9.4 Philippines Urticaria Treatment Market Opportunity Assessment, By Distribution Channel, 2021 & 2031F |
10 Philippines Urticaria Treatment Market - Competitive Landscape |
10.1 Philippines Urticaria Treatment Market Revenue Share, By Companies, 2024 |
10.2 Philippines Urticaria Treatment Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |